Literature DB >> 20503445

Clinical features of hepatitis B virus-related hepatocellular carcinoma.

Toru Ishikawa1.   

Abstract

Hepatocellular carcinoma (HCC) is a major cause of cancer death, and chronic hepatitis B is a serious worldwide problem. The epidemiology of HCC is distinctive. Hepatitis B virus (HBV) plays a major role in hepatocarcinogenesis. Prevention of HBV-related HCC is a key issue in current hepatology. This paper describes the prevention and clinical features of HBV-related HCC, along with a short review of the disease.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20503445      PMCID： PMC2877175          DOI： 10.3748/wjg.v16.i20.2463

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  25 in total

1.  Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Shoji Kubo; Kazuhiro Hirohashi; Osamu Yamazaki; Mitsuharu Matsuyama; Hiromu Tanaka; Katsuhiko Horii; Taichi Shuto; Takatsugu Yamamoto; Shuichi Kawai; Kenichi Wakasa; Shuhei Nishiguchi; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

2.  Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan.

Authors:  Etsuro Orito; Fuminaka Sugauchi; Yasuhito Tanaka; Takafumi Ichida; Michio Sata; Eiji Tanaka; Takeshi Okanoue; Hiroshi Sakugawa; Hisatsuyo Watanabe; Hiroshi Miyakawa; Shuhei Nishiguchi; Hiromitsu Kumada; Ryuzo Ueda; Masashi Mizokami
Journal:  Intervirology       Date:  2005       Impact factor: 1.763

3.  Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.

Authors:  N Nagasue; T Ono; A Yamanoi; H Kohno; O N El-Assal; H Taniura; M Uchida
Journal:  Br J Surg       Date:  2001-04       Impact factor: 6.939

4.  Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus.

Authors:  Shoji Kubo; Hiromu Tanaka; Shigekazu Takemura; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Hiroji Shinkawa; Hiroki Sakaguchi; Akihiro Tamori; Daiki Habu; Shuhei Nishiguchi
Journal:  Hepatol Res       Date:  2007-02       Impact factor: 4.288

5.  Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.

Authors:  S Roayaie; M B Haim; S Emre; T M Fishbein; P A Sheiner; C M Miller; M E Schwartz
Journal:  Ann Surg Oncol       Date:  2000-12       Impact factor: 5.344

6.  Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma.

Authors:  S Kubo; K Hirohashi; H Tanaka; T Tsukamoto; T Shuto; T Yamamoto; T Ikebe; K Wakasa; S Nishiguchi; H Kinoshita
Journal:  Cancer       Date:  2000-03-01       Impact factor: 6.860

Review 7.  Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients.

Authors:  Toru Ishikawa
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

8.  Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis.

Authors:  Takashi Someya; Kenji Ikeda; Satoshi Saitoh; Masahiro Kobayashi; Tetsuya Hosaka; Hitomi Sezaki; Norio Akuta; Fumitaka Suzuki; Yoshiyuki Suzuki; Yasuji Arase; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

9.  The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.

Authors:  Jeong Won Jang; Jong Young Choi; Si Hyun Bae; Seung Kew Yoon; Hyun Young Woo; U Im Chang; Chang Wook Kim; Soon Woo Nam; Se Hyun Cho; Jin Mo Yang; Chang Don Lee
Journal:  Cancer       Date:  2007-10-15       Impact factor: 6.860

10.  Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.

Authors:  H Okuda; H Obata; Y Motoike; T Hisamitsu
Journal:  Hepatogastroenterology       Date:  1984-04
View more
  15 in total

Review 1.  Natural regression of fibrosis in chronic hepatitis B.

Authors:  Shogo Ohkoshi; Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Kenya Kamimura; Masahiko Yano
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4.

Authors:  Chao Ye; Xiaoqian Zhang; Xinyu Chen; Qingyi Cao; Xiaobing Zhang; Yanwen Zhou; Wenxin Li; Liangjie Hong; Haiyang Xie; Xiaoli Liu; Hongcui Cao; Ying-Jie Wang; Bo Kang
Journal:  Cell Oncol (Dordr)       Date:  2019-12-17       Impact factor: 6.730

3.  Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.

Authors:  Makoto Meguro; Toru Mizuguchi; Toshihiko Nishidate; Kenji Okita; Masayuki Ishii; Shigenori Ota; Tomomi Ueki; Emi Akizuki; Koichi Hirata
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

4.  Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.

Authors:  Wing-Kin Sung; Hancheng Zheng; Shuyu Li; Ronghua Chen; Xiao Liu; Yingrui Li; Nikki P Lee; Wah H Lee; Pramila N Ariyaratne; Chandana Tennakoon; Fabianus H Mulawadi; Kwong F Wong; Angela M Liu; Ronnie T Poon; Sheung Tat Fan; Kwong L Chan; Zhuolin Gong; Yujie Hu; Zhao Lin; Guan Wang; Qinghui Zhang; Thomas D Barber; Wen-Chi Chou; Amit Aggarwal; Ke Hao; Wei Zhou; Chunsheng Zhang; James Hardwick; Carolyn Buser; Jiangchun Xu; Zhengyan Kan; Hongyue Dai; Mao Mao; Christoph Reinhard; Jun Wang; John M Luk
Journal:  Nat Genet       Date:  2012-05-27       Impact factor: 38.330

Review 5.  Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.

Authors:  Yi-Fang Han; Jun Zhao; Li-Ye Ma; Jian-Hua Yin; Wen-Jun Chang; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

6.  Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study.

Authors:  Jianxing Zeng; Kongying Lin; Huocheng Liu; Yao Huang; Pengfei Guo; Yongyi Zeng; Jinhua Zeng; Jingfeng Liu
Journal:  Cancer Manag Res       Date:  2020-07-30       Impact factor: 3.989

7.  HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC).

Authors:  Wenhui Wang; Yan Chen; Liang Wu; Yi Zhang; Seungyeul Yoo; Quan Chen; Shiping Liu; Yong Hou; Xiao-Ping Chen; Qian Chen; Jun Zhu
Journal:  BMC Med Genomics       Date:  2022-06-16       Impact factor: 3.622

Review 8.  Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions.

Authors:  Hong-Zhi Xu; Yun-Peng Liu; Bayasi Guleng; Jian-Lin Ren
Journal:  Gastrointest Tumors       Date:  2014-07-18

9.  Gene set enrichment analysis of microarray data from Pimephales promelas (Rafinesque), a non-mammalian model organism.

Authors:  Michael A Thomas; Luobin Yang; Barbara J Carter; Rebecca D Klaper
Journal:  BMC Genomics       Date:  2011-01-26       Impact factor: 3.969

10.  Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis.

Authors:  Qi Zhang; Guangwen Cao
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.